BCMab1-Ra, a novel immunotoxin that BCMab1 antibody coupled to Ricin A chain, can eliminate bladder tumor

Bladder cancer is one of the most common malignancies. However, there is no ideal therapy to cure bladder cancer so far, especially invasive carcinoma. Here, we developed a new antibody-based drug BCMab1-Ra, which was generated by conjugation of BCMab1 (a new monoclonal antibody that specifically re...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chong, Yan, Ruping, Yang, Zhao, Wang, Haifeng, Zhang, Ruiyun, Chen, Haige, Wang, Jiansong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542304/
https://www.ncbi.nlm.nih.gov/pubmed/28578321
http://dx.doi.org/10.18632/oncotarget.13504

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542304/
https://www.ncbi.nlm.nih.gov/pubmed/28578321
http://dx.doi.org/10.18632/oncotarget.13504

Ejemplares similares